Your browser doesn't support javascript.
loading
Protocatechuic acid inhibits rat pheochromocytoma cell damage induced by a dopaminergic neurotoxin.
Zhang, Hong-Ning; An, Chun-Na; Xu, Man; Guo, De-An; Li, Min; Pu, Xiao-Ping.
Afiliação
  • Zhang HN; State Key Laboratory of Natural and Biomimetic Drugs, Peking University, Xueyuan Road, Haidian District, Beijing 100191, P R China.
Biol Pharm Bull ; 32(11): 1866-9, 2009 Nov.
Article em En | MEDLINE | ID: mdl-19881299
ABSTRACT
Parkinson's disease (PD) is characterized by the progressive degeneration of dopaminergic neurons in the substantia nigra (SN) with the presence of alpha-synuclein inclusions termed Lewy bodies. The aggregation of alpha-synuclein into oligomeric species affects neuronal viability, having a causal role in the development of PD. The neuroprotective effects of protocatechuic acid (PAc) have been reported. However, the effects of PAc on tyrosine hydroxylase (TH) and alpha-synuclein in rat pheochromocytoma (PC12) cells treated with 1-methyl-4-phenylpyridinium ion (MPP(+)) remains unclear. In this study, we demonstrated that PAc inhibited the cytotoxicity, apoptotic morphology, reduction of TH expression and abnormal oligomeration of alpha-synuclein in PC12 cells treated with MPP(+). Taken together, our results indicate that the neuroprotective effects of PAc on PC12 cells treated with MPP(+) is related to the inhibition of the oligomerization of alpha-synuclein.
Assuntos
Buscar no Google
Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Feocromocitoma / Dopamina / Hidroxibenzoatos / Neurotoxinas Limite: Animals Idioma: En Ano de publicação: 2009 Tipo de documento: Article
Buscar no Google
Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Feocromocitoma / Dopamina / Hidroxibenzoatos / Neurotoxinas Limite: Animals Idioma: En Ano de publicação: 2009 Tipo de documento: Article